Results 1 to 10 of about 142,929 (208)

Mitral annular plane systolic excursion for assessing left ventricular systolic dysfunction in patients with septic shock

BJA Open, 2023
Background: Using easy-to-determine bedside measurements, we developed an echocardiographic algorithm for predicting left ventricular ejection fraction (LVEF) and longitudinal strain (LVLS) in patients with septic shock.
Clément Brault, Yoann Zerbib, Pablo Mercado, Momar Diouf, Audrey Michaud, Christophe Tribouilloy, Julien Maizel, Michel Slama   +7 more
doaj   +3 more sources

Left Ventricular Systolic Dysfunction in Patients of Obstructive Sleep Apnea Syndrome

Pakistan Armed Forces Medical Journal, 2023
Objective: To determine the left ventricular systolic dysfunction and the association of various factors with this dysfunction in patients with obstructive sleep apnea syndrome. Study Design: Cross-sectional study.
Zahra Asif Sukhera, Muhammad Zill-e-Hamayun Mirza, Rizwan Azam, Ibrahim Zafar Gondal, Asif Mumtaz Sukhera, Komal Arshad   +5 more
doaj   +3 more sources

Ross procedure in patients with severe left ventricular systolic dysfunction

Патология кровообращения и кардиохирургия, 2015
The Ross procedure outcomes in patients with left ventricular dysfunction are presented. 20 Ross procedures were performed in patients with aortic disease complicated by severe left ventricular dysfunction.
А. М. Караськов, И. И. Демин, С. И. Железнев, А. В. Богачев-прокофьев, Р. М. Шарифулин, О. И. Кулумбегов, Е. Е. Литасова, А. Б. Опен   +7 more
doaj   +4 more sources

The extracellular matrix degradation markers as predictors of left ventricular systolic dysfunction among patients with STEMI

Сучасні медичні технології, 2021
The purpose of the study. To determine predictor value of the extracellular matrix degradation markers relative to the occurrence of left ventricular systolic dysfunction among patients with STEMI determined. Materials and methods.
I. M. Fushtey, E. V. Sid
doaj   +2 more sources

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. [PDF]

JACC CardioOncol
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, but ICI myocarditis (ICI-M) remains a potentially fatal complication. The clinical implications and predictors of left ventricular ejection fraction (LVEF) 
Chen YC, Dolladille C, Rao A, Palaskas NL, Deswal A, Lehmann L, Cautela J, Courand PY, Hayek S, Zhu H, Cheng RK, Alexandre J, Baldassarre LA, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan EM, Johnson DB, Flint DL, Rainer PP, Bailly G, Ewer SM, Aras MA, Arangalage D, Cariou E, Florido R, Peretto G, Itzhaki Ben Zadok O, Akhter N, Narezkina A, Levenson JE, Liu Y, Crusz SM, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang WT, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang KW, Power JR, Moslehi J, Salem JE, Zaha VG, International ICI Myocarditis Registry.   +56 more
europepmc   +4 more sources

Effect of Left Ventricular Systolic Dysfunction on the Outcome of Mechanical Thrombectomy. [PDF]

J Neuroendovasc Ther
Left ventricular systolic dysfunction has traditionally been considered an unfavorable prognostic factor in stroke. However, chronic hypoperfusion due to this dysfunction may improve cerebral collateral flow, potentially serving as a compensatory mechanism during ischemic stroke.
Miyamoto S, Ito Y, Numao S, Tanaka S, Hiramine T, Takahashi T, Okune S, Hosoo H, Hayakawa M, Marushima A, Yamagami H, Ishikawa E, Matsumaru Y.   +12 more
europepmc   +4 more sources

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

Lancet, The, 1997
<p>Background In most previous epidemiological studies on the prevalence of chronic heart failure (CHF) the disorder has been defined on clinical criteria.
Ian Ford, H Tunstall-Pedoe, John J V Mcmurray   +2 more
exaly   +2 more sources

Rethinking Revascularization in Left Ventricular Systolic Dysfunction [PDF]

Circulation: Heart Failure, 2017
Patients with chronic heart failure with reduced ejection fraction (HFrEF) now have multiple therapeutic options, including oral medications and cardiac devices, that improve quality of life, reduce the risk of readmission, and improve mortality. In the span of only decades, the goals of treatment have moved dramatically upstream from supportive care ...
Adam D, DeVore, Eric J, Velazquez
openaire   +2 more sources

Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes

Journal of Cardiothoracic Surgery, 2020
Background This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction.
Jun Li, Yun Zhao, Tianyu Zhou, Yongshi Wang, Kai Zhu, Junyu Zhai, Yongxin Sun, Hao Lai, Chunsheng Wang   +8 more
doaj   +1 more source

Left Ventricular Systolic Dysfunction among Hypertensive Subjects [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Hypertension has been established as one of the most significant causes of heart failure. Left ventricular function is a useful measure in the assessment and prognostication of heart disease.
Anugya Aparajita Behera, Suresh Kumar Behera, Dipti Mohapatra, Arati Mohanty   +3 more
doaj   +1 more source